JAAD 02/24 Part I: Epidemiology, Pathophysiology, and Clinical Considerations of Primary and Secondary Raynaud’s Phenomenon

JAAD 03/24 Erythromelalgia. Part I: Pathogenesis, clinical features, evaluation, and complications

JAAD 02/24 Part II: The Treatment of Primary and Secondary Raynaud’s Phenomenon

JAAD 03/24 Erythromelalgia. Part II: Pathogenesis, clinical features, evaluation, and complications

JAAD 05/24 Drug-induced Hypersensitivity Syndrome / Drug Reaction with Eosinophilia and Systemic Symptoms. Part I. Epidemiology, Pathogenesis, Clinicopathological Features, and Prognosis.

JAAD 04/24 Performance Measurement Part I: Foundational Knowledge for Measure Development

JAAD 05/24 Drug-induced Hypersensitivity Syndrome / Drug Reaction with Eosinophilia and Systemic Symptoms. Part II. Diagnosis and Management.

JAAD 06/24 Acne scarring-pathophysiology, diagnosis, prevention and education – Part 1

JAAD 04/24 Performance Measurement Part II: A guide to developing dermatology performance measures

JAAD 06/24 Procedural and surgical treatment modalities for acne scarring – Part 2